Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: gelatin; butylated hydroxyanisole; glycerol; iron oxide red; iron oxide yellow; titanium dioxide; medium chain triglycerides; butylated hydroxytoluene; maize starch; sorbitol; mannitol - for the management of established post-menopausal osteoporosis by increasing calcium absorption, elevating circulating levels of calcitriol, and reducing vertebral fracture frequency. for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. for the treatment of hypoclacamia in patients with uraemic osteodystrophy, hypoparathyroidism and vitamin d resistant rickets. indications as at 4 march 2004: rocaltrol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of a traumatic fracture. rocaltrol is also indicated for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. rocaltrol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphatemic rickets.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: butylated hydroxyanisole; iron oxide red; purified water; gelatin; iron oxide yellow; fractionated coconut oil; glycerol; sorbitol solution (70 per cent) (non-crystallising); butylated hydroxytoluene - calciprox is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. calciprox is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. calciprox is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - calcitriol -

Arménsko - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

hoffmann-la roche ltd. - calcitriol - capsules - 0,25mcg

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - calcitriol - oral capsule - 250nanogram

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - calcitriol - oral capsule - 500nanogram

Spojené štáty - angličtina - NLM (National Library of Medicine)

roche pharmaceuticals - calcitriol (unii: fxc9231jvh) (calcitriol - unii:fxc9231jvh) - capsule, liquid filled - 0.25 ug - rocaltrol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (ccr 15 to 55 ml/min) not yet on dialysis. in children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. a serum ipth level of ≥ 100 pg/ml is strongly suggestive of secondary hyperparathyroidism. rocaltrol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. in these patients, rocaltrol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. rocaltrol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. rocalt

Singapur - angličtina - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - calcitriol - capsule, liquid filled - 0.25 mcg - calcitriol 0.25 mcg

Kanada - angličtina - Health Canada

odan laboratories ltd - calcitriol - capsule - 0.25mcg - calcitriol 0.25mcg - vitamin d

Kanada - angličtina - Health Canada

odan laboratories ltd - calcitriol - capsule - 0.5mcg - calcitriol 0.5mcg - vitamin d